CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks Investment Research • 11 hours ago

AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers

Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.

24/7 Wall Street • 12 hours ago

2 Stocks That Are Much Cheaper Than They Look

AbbVie and CVS Health may appear to be expensive stocks, as they trade at trailing price-to-earnings multiples of more than 40. Their earnings, however, look worse than they otherwise would be due to non-recurring expenses.

The Motley Fool • 11 hours ago

CVS Health study reveals a need for greater digital health literacy for Medicare members

Majority of respondents believe that low digital literacy is having a negative impact on their ability to manage their health  CVS Health continues to launch innovative digital offerings to help members access care, as part of its $20 billion technology investment, announced in 2025 WOONSOCKET, R.I., May 18, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS), today released "Navigating the Digital Health Literacy Gap," a research-based white paper revealing a significant gap between older Americans' current ability to navigate digital health tools and their interest and openness to learning more.

PRNewsWire • May 18, 2026

Here's Why CVS Health (CVS) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • May 18, 2026

Price Prediction: CVS Eyes 44% Upside After Aetna-Driven Q1 Surge

Our 24/7 Wall St. price target for CVS Health (NYSE:CVS | CVS Price Prediction) is $125.45, pointing to meaningful upside from where shares trade today.

24/7 Wall Street • May 14, 2026

CVS Sale Of Omnicare Long-Term Care Pharmacy Continues Portfolio Revamp

A bankruptcy court has approved the sale of CVS Health's underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million.

Forbes • May 14, 2026

CVS Health® and WGU launch online pre-pharmacy degree program for future pharmacists nationwide

New program helps reduce financial barriers to higher education while building a stronger, more robust pharmacy workforce WOONSOCKET, R.I., May 14, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) and WGU today announced a new online pre-pharmacy degree program designed to help address the national need for pharmacists through flexible, affordable education.

PRNewsWire • May 14, 2026

CVS unit Omnicare wins court approval for sale to GenieRx

Omnicare, a unit of health insurer CVS Health , said on Wednesday a U.S. bankruptcy court ​has approved the sale of its business ‌to GenieRx Holdings.

Reuters • May 13, 2026

MinuteClinic highlights access and outcomes in clinically supervised weight-loss program

In-person and virtual services support chronic disease prevention and long-term metabolic health WOONSOCKET, R.I., May 13, 2026 /PRNewswire/ -- As chronic conditions tied to metabolic health continue to rise across the United States, MinuteClinic®, the medical clinic inside select CVS Pharmacy® (NYSE: CVS) locations, is highlighting its clinically supervised weight-loss program to support earlier intervention and more accessible preventive care.

PRNewsWire • May 13, 2026